Bain Capital completes purchase of DSM Sinochem

Royal DSM and Sinochem Group have successfully completed the sale of DSM Sinochem Pharmaceuticals to Bain Capital Private Equity, following the earlier announcement of the transaction in June this year.

DSM Sinochem Pharmaceuticals develops, produces and sells intermediates, APIs and drug products. With its financial, advisory and operational capabilities combined with an extensive knowledge of the healthcare Spain, Bain will assist DSM in achieving its vision and support the company’s strategy and continued growth.

Reflecting the change in ownership as an independent global generics pharmaceutical company, DSM will launch a new corporate identity in December this year. Following this launch, the company will ensure a smooth transition for its customers, suppliers and partners.